Nutrichem's LDN Book Events with Linda Elsegood (Low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Book Volume 2 & The Goals of the LDN Research Trust

Low-dose naltrexone: tricking the body to heal itself

Exp Biol Med (Maywood)
September 2011
https://www.sciencedaily.com/releases/2011/09/110902133047.htm

Low Dose Naltrexone Treatment of Established Relapsing-Remitting Experimental Autoimmune Encephalomyelitis

J Multiple Sclerosis
January 2015
https://www.researchgate.net/publication/281496691_Low_Dose_Naltrexone_Treatment_of_Established_Relapsing-Remitting_Experimental_Autoimmune_Encephalomyelitis

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial

Mult Scler
August 2010
https://pubmed.ncbi.nlm.nih.gov/20534644/

Bee Venom Therapy and Low Dose Naltrexone for Treatment of Multiple Sclerosis

Nepal J Neurosci
January 2006
https://www.researchgate.net/publication/283504677_Bee_Venom_Therapy_and_Low_Dose_Naltrexone_for_Treatment_of_Multiple_Sclerosis

Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?

Med Hypotheses
February 2006
https://pubmed.ncbi.nlm.nih.gov/16759815/

Inducible nitric oxide synthase is thought to be responsible for inflammatory nitric oxide concentrations in the brains of patients with MS and those with autism. It is proposed that low-dose naltrexone reduces nitric oxide synthase, thus acts as an anti-inflammatory agent.
 

Low dose naltrexone therapy in multiple sclerosis

Med Hypotheses
24 September 2004
https://pubmed.ncbi.nlm.nih.gov/15694688/

Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics

Neurotherapeutics
October 2017
https://pubmed.ncbi.nlm.nih.gov/28779373/

Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study

PLoS One
03 November 2017
https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0187423

Featured Article: Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/